510(k) Report

510(k) · Cleared

Cleared

Non-Sterile Powder Free Blue Nitrile Examination Gloves Tested for Use with Chemotherapy Drugs

K172864510(k) TraditionalCleared May 2, 2018224-day reviewClass I21 CFR 880.6250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Maxter Glove Manufacturing Sdn Bhd · LZC Medical Glove, Specialty

Cleared on May 2, 2018 as substantially equivalent to K151750 (Kossan International Sdn Bhd, 2016) after a 224-day review. Its family tree reaches back 2 generations to 2009.

Decided
May 2, 2018
Review
224 days
Class
Class I
Product code
LZC
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K090412 (2009). No later device cites it as a predicate yet.

  1. Root · 2 generations backK090412 Powder Free Nitrile Examination Gloves (Pink, Green, Orange,White).Gx Corporation Sdn Bhd · 2009
  2. 1 generation backK151750 Powder Free Nitrile Patient Examination Glove, Blue Colored…Kossan International Sdn Bhd · 2016
  3. This deviceK172864 Non-Sterile Powder Free Blue Nitrile Examination Gloves Tested for…Maxter Glove Manufacturing Sdn Bhd · 2018
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K090412Powder Free Nitrile Examination Gloves (Pink, Green, Orange,White).Gx Corporation Sdn Bhd2009—
−1K151750Powder Free Nitrile Patient Examination Glove, Blue Colored, Non-Sterile…Kossan International Sdn Bhd2016—
0 (this device)K172864Non-Sterile Powder Free Blue Nitrile Examination Gloves Tested for Use with…Maxter Glove Manufacturing Sdn Bhd2018—
FIG. 1 — Lineage of K172864, 2009–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZC device

  1. #1 K201390 Medline Powder-Free Light Blue Nitrile Exam…score 19.2 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K151750Powder Free Nitrile Patient Examination Glove, Blue Colored, Non-Sterile, Powder Free…
Summary page 4
…Glove, Blue Colored, Non-Sterile. Tested for Use with Chemotherapy Drugs 510(k) Number K151750 Regulation Number 21 CFR 880.6250 Regulatory Name Patient Examinati…
Kossan International Sdn Bhd2016—

Also cleared against K151750: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 9 years and passes through 3 companies; a new generation was cleared every 7.2 years on median.
  • None of the 2 ancestors has a recall.
  • 2 other devices also cite its predicate K151750.

How does its category compare?

All LZC devices

LZC Medical Glove, Specialty: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · LZC

1in 2025

2007: 12008: 32009: 52010: 52012: 42015: 12016: 32017: 62018: 62019: 72020: 32021: 32022: 72025: 12026 (partial year): 1
2007high 7 (2019) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZC

85in 2022

2008: 166 days median2009: 253 days median2010: 68 days median2012: 149 days median2016: 258 days median2017: 121 days median2018: 105 days median2019: 200 days median2020: 167 days median2021: 94 days median2022: 85 days median
2007high 258 (2016) · low 68 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZC

1in 2021

2008: 12011: 42021: 12026 (partial year): 1
2007high 4 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LZC

10in 2025

2009: 12011: 12012: 12013: 12014: 32016: 52017: 72018: 62019: 82020: 12021: 22022: 22023: 12024: 162025: 10
2007high 16 (2024) · low 0 (2007)2025

MAUDE reports naming product code LZC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
2008316610
2009525301
201056800
20110—41
2012414901
20130—01
20140—03
20151—00
2016325805
2017612107
2018610506
2019720008
2020316701
202139412
202278502
20230—01
20240—016
20251—010
20261—1—

What is it indicated for?

A powder free nitrile examination glove is a disposable device intended for medical purposes that is worn on the examiner's hands and finger to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTMD6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs: Tested Chemotherapy Drug and Concentration Minimum Breakthrough…

Read the full statement (159 words)

A powder free nitrile examination glove is a disposable device intended for medical purposes that is worn on the examiner's hands and finger to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTMD6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs:

Tested Chemotherapy Drug and Concentration Minimum Breakthrough Detection Time (Minutes)

Carmustine (BCNU). 3.3mg/ml (3,300ppm) 8.3

Cisplatin. 1.0 mg/ml (1,000ppm) >240

Cyclophosphamide (Cytoxan). 20mg/ml (20,000ppm) >240

Cytarabine 100mg/ml (100,000ppm) >240

Dacarbazine (DTIC), 10.0mg/ml (10,000ppm) >240

Doxorubicin Hydrochloride. 2.0mg/ml (2,000ppm) >240

Etoposide (Toposar), 20.0mg/ml (20,000ppm) >240

Fluorouracil 50.0mg/ml (50,000ppm) >240

Ifosfamide. 50.Omg/ml (50,000ppm) >240

Methotrexate 25mg/ml (25,000ppm) >240

Mitomycin C. 0.5mg/ml (500ppm) >240

Mitoxantrone 2.0mg/ml (2,000ppm) >240

Paclitaxel (Taxol). 6.0mg/ml (6,000ppm) >240

Thiotepa. 10.0mg/ml (10,000ppm) 38.0

Vincristine Sulfate 1.0mg/ml (1,000ppm) >240

Please note that the following drugs have low permeation time of less than 240minutes:

Carmustine (BCNU), 3.3mg/ml: 8.3 Minutes

Thiotepa. 10.0mg/ml: 38.0 Minutes

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K172864: Non-Sterile Powder Free Blue Nitrile Examination Gloves Tested for Use with Chemotherapy Drugs.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K172864

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026